These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1580637)
1. [Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer]. Namatame K; Sasaki E; Koh Y; Shimada K; Nakamura T; Hirose T; Ookubo M; Nakayoshi A Gan To Kagaku Ryoho; 1992 May; 19(5):625-30. PubMed ID: 1580637 [TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy]. Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643 [TBL] [Abstract][Full Text] [Related]
3. [FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer]. Hayakawa M; Morise K; Oka Y; Suga S; Suzuki T; Kaneshiro K; Tsunekawa H; Hayashi N; Umemura K; Yoshida H Gan To Kagaku Ryoho; 1988 Nov; 15(11):3073-9. PubMed ID: 2847659 [TBL] [Abstract][Full Text] [Related]
4. [FLEP therapy for advanced and recurrent gastric cancer]. Mochizuki F; Fujii M; Kasakura Y; Kochi M; Wakabayashi K; Eguchi T; Tsuneda Y; Kanamori N; Kaiga T; Kobayashi M Gan To Kagaku Ryoho; 2001 Oct; 28(11):1542-5. PubMed ID: 11707975 [TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer]. Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer. Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer. Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107 [TBL] [Abstract][Full Text] [Related]
8. [A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide]. Ono T; Komatsu M; Hoshino T; Ishii T; Fujii K; Ohshima S; Mikami K; Masamune O; Fukuda T Gan To Kagaku Ryoho; 1996 Oct; 23(12):1709-12. PubMed ID: 8886050 [TBL] [Abstract][Full Text] [Related]
9. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma. Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer]. Yabusaki H; Nashimoto A; Tanaka O Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962 [TBL] [Abstract][Full Text] [Related]
11. [New interesting chemotherapeutic regimens in advanced gastric cancer]. Taguchi T Gan To Kagaku Ryoho; 1991 May; 18(6):945-51. PubMed ID: 1709348 [TBL] [Abstract][Full Text] [Related]
12. [A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach]. Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Tokisue M; Ohno S; Masuda T Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):397-401. PubMed ID: 2138004 [TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide]. Kato M; Kinoshita K; Sawa T; Yoshimitsu S; Tomita F; Takano Y; Segawa M; Ohyama S; Yonemura Y; Miwa K Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):391-6. PubMed ID: 2106835 [TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group]. Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870 [TBL] [Abstract][Full Text] [Related]
15. [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. Hasegawa Y; Honnma S; Takanashi K; Yajima K; Nakashima Y Gan To Kagaku Ryoho; 1991 Aug; 18(11):2047-51. PubMed ID: 1908669 [TBL] [Abstract][Full Text] [Related]
16. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer. Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study. Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092 [TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer]. Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183 [TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of adjuvant chemotherapy using 5-fluorouracil, leucovorin and cis-diamminedichloroplatinum for patients with advanced and recurrent gastric cancer]. Katsumata K; Yamamoto K; Ohno M; Shibata K; Yamashita S; Moriwaki R; Kohno M; Tadatomo H; Koyanagi Y Gan To Kagaku Ryoho; 1997 Feb; 24(3):309-14. PubMed ID: 9051133 [TBL] [Abstract][Full Text] [Related]
20. [Two cases of advanced and recurrent gastric cancer responding markedly to TS-1/CDDP therapy]. Ishiyama T; Nakamura T; Suzuki T; Inazawa K Gan To Kagaku Ryoho; 2004 Mar; 31(3):415-7. PubMed ID: 15045952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]